http://www.zibb.com/all/theme/cq/BioSante+Pharmaceuticals,+Incorporated Zibb. The Global business search engine. en-US search@zibb.com (RB Search)Copyright (c) 2007 Reed Business Information. All rights reserved.Wed, 25 Nov 2009 04:42:03 GMTWed, 25 Nov 2009 04:42:03 GMT608831http://www.zibb.com/all/theme/cq/BioSante+Pharmaceuticals,+Incorporated http://www.zibb.com/images/en/g_zibb_logo_beta.gif http://www.newsrx.com/article.php?articleID=479926If you have an account with NewsRx and have purchased either a NewsRx Bundled package or a NewsRx Pass, you can log into your account below to access this article.http://www.newsrx.com/article.php?articleID=479926BioSante Pharmaceuticals, Incorporatedhttp://www.nanotechwire.com/news.asp?nid=6071/7/2004 9:39:58 PM BioSante Pharmaceuticals Announces DynPort Subcontract to Develop Anthrax Vaccines Using Nanotechnology-Based Alternative Delivery Systemshttp://www.nanotechwire.com/news.asp?nid=607BioSante Pharmaceuticals, Incorporatedhttp://www.newratings.com/headlines/BioSante-Pharmaceuticals_US09065V2034.htmlCopyright © 2002 - 2008 newratings.com GmbH | Legal | Licensing Quote data provided by IS.eFinance Solutions (powered by IS.Teledata AG) using StandardPoor's ComStock Inc. and others. Delay times are 15 mins for European exchanges and NASDAQ, 20 mins for NYSE and AMEX.http://www.newratings.com/headlines/BioSante-Pharmaceuticals_US09065V2034.htmlBioSante Pharmaceuticals, Incorporatedhttp://www.pharmacychoice.com/News/article.cfm?Article_ID=12641LINCOLNSHIRE, Ill.--(BUSINESS WIRE)--Sept. 13, 2005--BioSante Pharmaceuticals (AMEX:BPA) today announced that Stephen M. Simes, president and chief executive officer, will present a corporate overview at Wall Street Reporter magazine's sixth annual Small-Cap Discovery Conference.http://www.pharmacychoice.com/News/article.cfm?Article_ID=12641BioSante Pharmaceuticals, Incorporatedhttp://www.nsti.org/press/PRshow.html?id=2284LINCOLNSHIRE, Ill.--(BUSINESS WIRE)--BioSante Pharmaceuticals, Inc. (Amex: BPA) today announced that it will host a conference call tomorrow, Tuesday, September 11, 2007 at 8:30 a.m. ET to provide an update on U.S.http://www.nsti.org/press/PRshow.html?id=2284BioSante Pharmaceuticals, Incorporatedhttp://www.chicagobusiness.com/cgi-bin/relatedStories.pl?type=company&id=1833BioSante shares jump on FDA approval of Bio-E-Gel (AP) — BioSante Pharmaceuticals Inc. said Monday the Food and Drug Administration approved its Bio-E-Gel, which treats hot flashes associated with menopause. Shares of Lincolnshire-based BioSante jumped on the news, rising 60 cents, or 23.http://www.chicagobusiness.com/cgi-bin/relatedStories.pl?type=company&id=1833BioSante Pharmaceuticals, Incorporatedhttp://www.amex.com/equities/listCmp/EqLCCmpDesc.jsp?Product_Symbol=BPABioSante Pharmaceuticals, Inc., in the development stage as of Dec. 31, 2005, is developing a pipeline of hormone therapy products to treat men and women.http://www.amex.com/equities/listCmp/EqLCCmpDesc.jsp?Product_Symbol=BPABioSante Pharmaceuticals, Incorporatedhttp://www.bloomberg.com/apps/news?pid=conewsstory&refer=conews&tkr=BPA:US&sid=a3PGCXiKVxJcLINCOLNSHIRE, Ill.--(BUSINESS WIRE)--May 16, 2007 BioSante Pharmaceuticals (AMEX: BPA) today announced that Stephen M. Simes, president and chief executive officer, will present a corporate overview at two upcoming conferences. The conferences are:http://www.bloomberg.com/apps/news?pid=conewsstory&refer=conews&tkr=BPA:US&sid=a3PGCXiKVxJcBioSante Pharmaceuticals, Incorporatedhttp://www.pharmacychoice.com/News/article.cfm?Article_ID=45125Bio-E-Gel has been shown to be effective at a daily dose of estradiol that is 50% lower than the lowest dose currently available for the treatment of hot flashes.http://www.pharmacychoice.com/News/article.cfm?Article_ID=45125BioSante Pharmaceuticals, Incorporatedhttp://www.pharmacychoice.com/News/article.cfm?Article_ID=29555BIOWIRE2K 5th Annual Needham & Company Biotechnology & Medical Technology Conference LINCOLNSHIRE, Ill.--(BUSINESS WIRE)--June 15, 2006--BioSante Pharmaceuticals, Inc. (Amex:BPA) today announced that Stephen M.http://www.pharmacychoice.com/News/article.cfm?Article_ID=29555BioSante Pharmaceuticals, Incorporatedhttp://www.pharmacychoice.com/News/article.cfm?Article_ID=180The independent panel of health professionals met during the NIH's State-of-the-Science Conference on the Management of Menopause-Related Symptoms, held March 21-23, 2005 in Bethesda, Maryland.http://www.pharmacychoice.com/News/article.cfm?Article_ID=180BioSante Pharmaceuticals, Incorporatedhttp://www.pharmacychoice.com/News/article.cfm?Article_ID=40618Rodman & Renshaw Healthcare Conference 2006 LINCOLNSHIRE, Ill.--(BUSINESS WIRE)--Nov. 3, 2006--BioSante Pharmaceuticals, Inc. (Amex: BPA) today announced that Stephen M.http://www.pharmacychoice.com/News/article.cfm?Article_ID=40618BioSante Pharmaceuticals, Incorporatedhttp://www.pharmacychoice.com/News/article.cfm?Article_ID=58082ILSI-Biomed Israel 2007 Needham Biotechnology & Medical Technology Conference 2007 RedChip Small-Cap Investor Conference LINCOLNSHIRE, Ill.--(BUSINESS WIRE)--May 30, 2007--BioSante Pharmaceuticals (AMEX:BPA) today announced that Stephen M.http://www.pharmacychoice.com/News/article.cfm?Article_ID=58082BioSante Pharmaceuticals, Incorporatedhttp://www.pharmacychoice.com/News/article.cfm?Article_ID=33450BIOWIRE2K LINCOLNSHIRE, Ill.--(BUSINESS WIRE)--Aug. 14, 2006--BioSante Pharmaceuticals, Inc. (AMEX:BPA) today reported its financial results for the second quarter and six months ended June 30, 2006.http://www.pharmacychoice.com/News/article.cfm?Article_ID=33450BioSante Pharmaceuticals, Incorporatedhttp://www.pharmacychoice.com/News/article.cfm?Article_ID=22183BIOWIRE2K 8th Annual BIO CEO & Investor Conference LINCOLNSHIRE, Ill.--(BUSINESS WIRE)--Feb. 13, 2006--BioSante Pharmaceuticals, Inc. (AMEX:BPA) today announced that Stephen M.http://www.pharmacychoice.com/News/article.cfm?Article_ID=22183BioSante Pharmaceuticals, Incorporatedhttp://www.pharmacychoice.com/News/article.cfm?Article_ID=24959BIOWIRE2K LINCOLNSHIRE, Ill.--(BUSINESS WIRE)--March 31, 2006--BioSante Pharmaceuticals, Inc. (Amex:BPA) today announced updated product development highlights, recent milestones and financial results for the year ended December 31, 2005.http://www.pharmacychoice.com/News/article.cfm?Article_ID=24959BioSante Pharmaceuticals, Incorporatedhttp://www.pharmacychoice.com/News/article.cfm?Article_ID=10714This license, which covers all potential routes of administration, follows BioSante's existing license to triple hormone therapy for menopausal women. Data indicate that a woman's testosterone levels decrease by approximately 30 to 50 percent between her 20s and 40s.http://www.pharmacychoice.com/News/article.cfm?Article_ID=10714BioSante Pharmaceuticals, Incorporatedhttp://www.pharmacychoice.com/News/article.cfm?Article_ID=12794The partner company will fund its development of potential products for the treatment of conditions including rhinitis, asthma, conjunctivitis, dermatitis, and allergic gastrointestinal diseases.http://www.pharmacychoice.com/News/article.cfm?Article_ID=12794BioSante Pharmaceuticals, Incorporatedhttp://www.pharmacychoice.com/News/topic.cfm?TOPIC_ID=3&View=OldPharmacy Choice - online community for the pharmacist, pharmacy technician and pharmacy student, offering pharmacy jobs, continuing education, pharmaceutical news and drug data.http://www.pharmacychoice.com/News/topic.cfm?TOPIC_ID=3&View=OldBioSante Pharmaceuticals, Incorporatedhttp://www.bloomberg.com/apps/news?pid=conewsstory&refer=conews&tkr=BPA:US&sid=aZwMdKlr2V9MLINCOLNSHIRE, Ill.--(BUSINESS WIRE)--May 02, 2007 BioSante Pharmaceuticals (AMEX:BPA) today announced that Stephen M. Simes, president and chief executive officer, will present a corporate overview at two upcoming conferences. The conferences are:http://www.bloomberg.com/apps/news?pid=conewsstory&refer=conews&tkr=BPA:US&sid=aZwMdKlr2V9MBioSante Pharmaceuticals, Incorporatedhttp://www.bloomberg.com/apps/news?pid=conewsstory&refer=conews&tkr=BPA:US&sid=anWayoyhYDOgLINCOLNSHIRE, Ill.--(BUSINESS WIRE)--May 30, 2007 BioSante Pharmaceuticals (AMEX:BPA) today announced that Stephen M. Simes, its president and chief executive officer, will present a corporate overview and update at upcoming conferences. The conferences are:http://www.bloomberg.com/apps/news?pid=conewsstory&refer=conews&tkr=BPA:US&sid=anWayoyhYDOgBioSante Pharmaceuticals, Incorporatedhttp://www.bloomberg.com/apps/news?pid=conewsstory&refer=conews&tkr=BPA:US&sid=aBegRFntRFTALINCOLNSHIRE, IL -- (MARKET WIRE) -- 05/08/07 -- BioSante Pharmaceuticals, Inc. (AMEX: BPA) will be featured in an exclusive Market News First interview May 9, 2007 at 1:15 PM CDT. Chief Executive Officer, Stephen Simes will talk with the MN1 news team on www.mn1.http://www.bloomberg.com/apps/news?pid=conewsstory&refer=conews&tkr=BPA:US&sid=aBegRFntRFTABioSante Pharmaceuticals, Incorporatedhttp://www.bloomberg.com/apps/news?pid=conewsstory&refer=conews&tkr=BPA:US&sid=a7zA.sm2R5SELINCOLNSHIRE, IL -- (MARKET WIRE) -- 05/31/07 -- BioSante Pharmaceuticals, Inc. (AMEX: BPA) President and CEO Stephen M. Simes will appear on Market News First broadcast on June 1, 2007 at 2:00 PM CDT. Mr. Simes will speak with MN1 host Kate Delaney on www.mn1.http://www.bloomberg.com/apps/news?pid=conewsstory&refer=conews&tkr=BPA:US&sid=a7zA.sm2R5SEBioSante Pharmaceuticals, Incorporated